Kendall Capital Management’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,964
Closed -$465K 219
2024
Q3
$465K Sell
10,964
-4,730
-30% -$248K 0.14% 149
2024
Q2
$804K Sell
15,694
-2,650
-14% -$150K 0.27% 101
2024
Q1
$1.15M Buy
18,344
+2,495
+16% +$170K 0.39% 80
2023
Q4
$1.19M Buy
15,849
+3,535
+29% +$253K 0.46% 70
2023
Q3
$1.05M Buy
12,314
+1,969
+19% +$187K 0.47% 68
2023
Q2
$1.13M Buy
10,345
+710
+7% +$67.3K 0.49% 66
2023
Q1
$799K Buy
9,635
+3,590
+59% +$338K 0.38% 88
2022
Q4
$622K Buy
6,045
+2,175
+56% +$250K 0.31% 104
2022
Q3
$410K Buy
3,870
+1,549
+67% +$170K 0.24% 117
2022
Q2
$255K Buy
+2,321
New +$230K 0.14% 147

Other funds holding AMN

Kendall Capital Management's AMN Position: Q4 2024 in Review

Kendall Capital Management sold out of AMN Healthcare (AMN) in Q4 2024, closing a stake of 10,964 shares — an estimated $465K sold.

Kendall Capital Management first reported a position in AMN in Q2 2022 and held it in 10 quarters. The position peaked at $1.19M in Q4 2023. 278 funds tracked by Wall St. Rank hold AMN as of Q4 2024.

  • Kendall Capital Management reported no remaining AMN Healthcare position as of Q4 2024 after selling out during the quarter.
  • Kendall Capital Management sold 10,964 AMN Healthcare shares in Q4 2024, an estimated $465K.
  • Kendall Capital Management first reported a position in AMN Healthcare in Q2 2022 and held it in 10 quarters.
  • Kendall Capital Management's AMN Healthcare position peaked at $1.19M in Q4 2023.
  • 278 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2024.

Based on Kendall Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.